Key result
Beta-blockers require individualization based on pathology and ventricular function as recent studies question routine use.
Its licence doesn't allow us to show a copy here.
Why the study?
Contemporary randomized trials and large population analyses have reshaped the understanding of appropriate beta-blocker use, questioning routine use across several cardiovascular scenarios.
Contemporary evidence suggests beta-blocker therapy should be individualized rather than routinely applied across all cardiovascular conditions, particularly questioning their historical use in MI with preserved EF and stable CAD.
Supports individualized beta-blocker use by LVEF and symptoms; challenges routine indications but leaves confirmation to prospective RCTs.
Beta-blockers have long been a foundational pharmacotherapy in cardiovascular care across many disease conditions. However, the emergence of contemporary randomized trials and large population analyses has reshaped our understanding of their appropriate use. This review highlights well established indications, such as chronic heart failure with reduced ejection fraction and angina, while also examining recent studies that have questioned routine use in certain scenarios such as myocardial infarction in patients with preserved ejection fraction, stable coronary artery disease, heart failure with preserved ejection fraction, first-line antihypertensive therapy, and perioperative management. Evolving data suggest that benefits are more nuanced than previously recognized and must be individualized based on underlying pathology, ventricular function, and symptomatic burden. This article provides a practical, indication-focused framework and identifies areas where further evidence is needed to refine prescribing and deprescribing practices.
No takes yet. Share an insight, caveat, or question.
Sperry et al. (2026) conducted a review in Cardiovascular disease. Beta-blockers was evaluated. Beta-blocker therapy must be individualized based on underlying pathology, ventricular function, and symptomatic burden, as recent studies question their routine use in certain clinical scenarios.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: